Stuart Chipkin

Research Professor and Board-Certified Endocrinologist

Dr. Chipkin has a long-standing interest in understanding ways to reduce the cardiovascular complications of diabetes mellitus. He has studied interactions between medications and lifestyle factors such as diet and physical activity. Funded projects have included both clinical trials and public health programs. He has been funded by local donors, private foundations, state agencies and the federal government.

Cardiovascular disease is the major cause of death for people with diabetes. The rising rates of obesity and pre-diabetes have further raised the risk for heart disease and stroke among people with “metabolic syndrome” which includes the clustering of high blood pressure, high cholesterol, excess body fat and abnormal blood sugar levels. Dr. Chipkin has studied these problems utilizing a range of approaches from clinical trials to public health programs. He is happy to discuss clinical applicability of any project.

Prior to his appointment at UMass, Dr. Chipkin was a faculty member of Tufts University Medical School for seven years and Boston University School of Medicine for 10 years.

Academic Background:

BS Emory Unviersity, Atlanta GA
MD SUNY Downstate, Brooklyn, NY
Fellowship (Endocrinology, Diabetes and Metabolism)- UMass Worcester

expand

Publications

Panza GA, Taylor BA, Thompson PD, Erhard L, Capizzi JA, Grimaldi AS, Cole SM, Chipkin S, Keadle J, White CM, Pescatello LS; The Effect of Atorvastatin on Habitual Physical Activity among Healthy Adults. Med Sci Sports Exerc. 48(1):1-6. doi: 10.1249/MSS.0000000000000740.

Han H, Lim J, Viskochil, R, Aguiar EJ, Tudor-Locke C, Chipkin SR; Impact of a pedal-desk on post-meal glucose and free fatty acids in sedentary workers. Med Sci Sports Exerc. 2018 Jun 1. doi: 10.1249/MSS.0000000000001679. [Epub ahead of print]; PMID:29864080.

Malin SK, Nightingale J, Choi SE, Chipkin SR, Braun B; Effects of exercise training on cardiovascular disease risk factors in individuals with impaired glucose tolerance. Obesity, 21: 93-100.

Parker BA, Capizzi JA, Grimaldi AS, Clarkson PM, Cole SM, Keadle J, Chipkin SR, Pescatello, LS, Simpson K, White CM and Thompson PD. The Effect of Statins on Skeletal Muscle Function. Circulation, 127:96-103.

Xin L, Hyldahl R, Chipkin SR, Clarkson P; A contralateral repeated bout effect attenuates induction of NF- κB DNA-binding following eccentric exercise. J Appl Phys, 116:1473-80.

Taylor BA, Panza G, Pescatello LS, Chipkin S, Gipe D, Shao W, White CM, Thompson PD; Serum PCSK9 Levels Distinguish Individuals Who Do Not Respond to High-Dose Statin Therapy with the Expected Reduction in LDL-C. J Lipids. doi: 10.1155/2014/140723.

Zaleski A, Mentch M, Taylor B, Capizzi J, Grimaldi A, Clarkson P, Moeckel-Cole SA, Chipkin SR, Keadle J, White CM, Thompson P and Pescatello L; Effects of Atorvastatin on Resting and Peak Exercise Blood Pressure Among Normotensive Men and Women. Cholesterol. doi:10.1155/2014/720507.

Hyldahl RD, Nelson B, Xin L, Welling T, Groscost L, Hubal MJ, Chipkin S, Clarkson PM, Parcell AC; Extracellular matrix remodeling and its contribution to protective adaptation following lengthening contractions in human muscle. FASEB J. doi: 10.1096/fj.14-266668.

Stuart Chipkin

Institute for Applied Life Sciences